BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 22854984)

  • 1. Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
    Cheng NM; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Liao CT; Lin CY; Hsu CL; Yen TC
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1673-84. PubMed ID: 22854984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
    Cheng NM; Fang YH; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Lin CY; Liao CT; Yen TC
    J Nucl Med; 2013 Oct; 54(10):1703-9. PubMed ID: 24042030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraindividual homogeneity of
    Sharma SJ; Wittekindt C; Knuth J; Steiner D; Wuerdemann N; Laur M; Kroll T; Wagner S; Klussmann JP
    Oral Oncol; 2017 Oct; 73():166-171. PubMed ID: 28939071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
    Schouten CS; Hakim S; Boellaard R; Bloemena E; Doornaert PA; Witte BI; Braakhuis BJ; Brakenhoff RH; Leemans CR; Hoekstra OS; de Bree R
    Head Neck; 2016 Apr; 38(4):529-35. PubMed ID: 25352335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?
    Kendi AT; Magliocca K; Corey A; Nickleach DC; Galt J; Higgins K; Beitler JJ; El-Deiry MW; Wadsworth JT; Hudgins PA; Saba NF; Schuster DM
    Clin Nucl Med; 2015 Mar; 40(3):e196-200. PubMed ID: 25608156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus-Positive Versus Human Papillomavirus-Negative Patients With Oropharyngeal Cancer.
    Gouw ZAR; La Fontaine MD; van Kranen S; van de Kamer JB; Vogel WV; van Werkhoven E; Sonke JJ; Al-Mamgani A
    Clin Nucl Med; 2019 May; 44(5):e323-e328. PubMed ID: 30889002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer.
    Cheng NM; Fang YH; Lee LY; Chang JT; Tsan DL; Ng SH; Wang HM; Liao CT; Yang LY; Hsu CH; Yen TC
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):419-28. PubMed ID: 25339524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by (18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity.
    Ryu IS; Kim JS; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
    Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):452-61. PubMed ID: 24081448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.
    Lim R; Eaton A; Lee NY; Setton J; Ohri N; Rao S; Wong R; Fury M; Schöder H
    J Nucl Med; 2012 Oct; 53(10):1506-13. PubMed ID: 22895812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
    Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim MS
    Head Neck; 2014 Mar; 36(3):323-7. PubMed ID: 23729374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.
    Alluri KC; Tahari AK; Wahl RL; Koch W; Chung CH; Subramaniam RM
    AJR Am J Roentgenol; 2014 Oct; 203(4):897-903. PubMed ID: 25247958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric
    Chotchutipan T; Rosen BS; Hawkins PG; Lee JY; Saripalli AL; Thakkar D; Eisbruch A; El Naqa I; Mierzwa ML
    Head Neck; 2019 Feb; 41(2):366-373. PubMed ID: 30548704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.
    Taghipour M; Marcus C; Califano J; Fakhry C; Subramaniam RM
    J Med Imaging Radiat Oncol; 2015 Dec; 59(6):681-6. PubMed ID: 26768092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT as a semiquantitative imaging marker in HPV-p16-positive oropharyngeal squamous cell cancers.
    Huang YT; Ravi Kumar AS; Bhuta S
    Nucl Med Commun; 2015 Jan; 36(1):16-20. PubMed ID: 25340950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of metabolic parameters of (18)F-FDG PET-CT scan performed during radiation therapy in locally advanced head and neck squamous cell carcinoma.
    Min M; Lin P; Lee MT; Shon IH; Lin M; Forstner D; Bray V; Chicco A; Tieu MT; Fowler A
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):1984-94. PubMed ID: 26081941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumors.
    Tahari AK; Alluri KC; Quon H; Koch W; Wahl RL; Subramaniam RM
    Clin Nucl Med; 2014 Mar; 39(3):225-31. PubMed ID: 24152652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
    Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.
    Chan JY; Sanguineti G; Richmon JD; Marur S; Gourin CG; Koch W; Chung CH; Quon H; Bishop JA; Aygun N; Agrawal N
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1040-6. PubMed ID: 23165378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.